Jeffrey Axler

Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis

Brian G. Feagan, Paul Rutgeerts, Bruce E. Sands et al. · New England Journal of Medicine · 2013 · 2.9K citations · Full text

Pharmacy, Immunology, Pharmacotherapy +15

Breath pentane analysis as an index of lipid peroxidation: a functional test of vitamin E status

Michel Lemoyne, A. Van Gossum, Regina Kurian et al. · American Journal of Clinical Nutrition · 1987 · 142 citations

Life Sciences, Biochemistry, Human Nutrition +14

Efficacy and Safety of Vedolizumab in Ulcerative Colitis and Crohn’s Disease Patients Stratified by Age

Vijay Yajnik, Nabeel Khan, Marla C. Dubinsky et al. · Advances in Therapy · 2017 · 94 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +16

Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial

Laurent Peyrin‐Biroulet, Ailsa Hart, Peter Bossuyt et al. · ˜The œLancet. Gastroenterology & hepatology · 2021 · 93 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +15

Budesonide Multimatrix Is Efficacious for Mesalamine-refractory, Mild to Moderate Ulcerative Colitis: A Randomised, Placebo-controlled Trial

David T. Rubin, Russell D. Cohen, William J. Sandborn et al. · Journal of Crohn s and Colitis · 2017 · 75 citations · Full text

Pharmacy, Pharmacotherapy, Clinical Pharmacology +15